Assessment of the Safety and Efficacy of the Novel Tetrapeptide ITF-1697 on Infarct Size after Primary PTCA in Acute Myocardial Infarction: A Randomised, Placebo-Controlled Pilot Trial

By Syeda B.   Kiss K.   Modarressy K.   Schönau K.   Schukro C.   Derntl M.   Laggner A.   Sochor H.   Glogar D.  

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 141-151

Adis International

Access to resources Recommend Favorite

Reduction of Myocardial Infarct Size by Dronedarone in Pigs—A Pleiotropic Action?

By Skyschally Andreas  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 3, 2011-06 ,pp. : 197-201

Springer Publishing Company

Access to resources Recommend Favorite

Cardioprotective-Mimetics Reduce Myocardial Infarct Size in Animals Resistant to Ischemic Preconditioning

By Gumina Richard   Schultz Jo El   Moore Jeanine   Beier Norbert   Schelling Pierre   Gross Garrett  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 5, 2005-10 ,pp. : 315-322

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size

By Sbarouni E.   Iliodromitis E.K.   Bofilis E.   Kyriakides Z.S.   Kremastinos D.T.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 163-168

Elsevier

Access to resources Recommend Favorite

Certain vaccines reduce mortality in developing countries?

By  

Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite